{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T04:04:31Z","timestamp":1748923471270,"version":"3.41.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,2]]},"DOI":"10.7759\/cureus.85232","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:49:33Z","timestamp":1748872173000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Subsyndromal Delirium With Daridorexant and Quetiapine: A Case Report"],"prefix":"10.7759","author":[{"given":"Keitaro","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Kiryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadafumi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Tamune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1765-3","article-title":"Outcomes of subsyndromal delirium in ICU: a systematic review and meta-analysis","volume":"21","author":"Serafim RB","year":"2017","unstructured":"Serafim RB, Soares M, Bozza FA, et al.. Outcomes of subsyndromal delirium in ICU: a systematic review and meta-analysis. Crit Care. 2017, 21:179. 10.1186\/s13054-017-1765-3","journal-title":"Crit Care"},{"key":"ref2","article-title":"The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision","author":"American Psychiatric Association","year":"2022","unstructured":"American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. American Psychiatric Association, 2022."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-4063-z","article-title":"Benzodiazepine-associated delirium in critically ill adults","volume":"41","author":"Zaal IJ","year":"2015","unstructured":"Zaal IJ, Devlin JW, Hazelbag M, et al.. Benzodiazepine-associated delirium in critically ill adults. Intensive Care Med. 2015, 41:2130-7. 10.1007\/s00134-015-4063-z","journal-title":"Intensive Care Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.27691","article-title":"Suvorexant for reduction of delirium in older adults after hospitalization: a randomized clinical trial","volume":"7","author":"Hatta K","year":"2024","unstructured":"Hatta K, Kishi Y, Wada K, et al.. Suvorexant for reduction of delirium in older adults after hospitalization: a randomized clinical trial. JAMA Netw Open. 2024, 7:e2427691. 10.1001\/jamanetworkopen.2024.27691","journal-title":"JAMA Netw Open"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2023.101746","article-title":"Efficacy and tolerability of pharmacological treatments for insomnia in adults: a systematic review and network meta-analysis","volume":"68","author":"Yue JL","year":"2023","unstructured":"Yue JL, Chang XW, Zheng JW, et al.. Efficacy and tolerability of pharmacological treatments for insomnia in adults: a systematic review and network meta-analysis. Sleep Med Rev. 2023, 68:101746. 10.1016\/j.smrv.2023.101746","journal-title":"Sleep Med Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2021.0509","article-title":"Pilot study of lemborexant for insomnia in cancer patients with delirium","volume":"25","author":"Terada T","year":"2022","unstructured":"Terada T, Hirayama T, Sadahiro R, Wada S, Nakahara R, Matsuoka H. Pilot study of lemborexant for insomnia in cancer patients with delirium. J Palliat Med. 2022, 25:797-801. 10.1089\/jpm.2021.0509","journal-title":"J Palliat Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/10398562221092310","article-title":"Lemborexant, an orexin receptor antagonist sedative-hypnotic: is it useful for insomnia in psychiatric disorders?","volume":"30","author":"Keks NA","year":"2022","unstructured":"Keks NA, Hope J. Lemborexant, an orexin receptor antagonist sedative-hypnotic: is it useful for insomnia in psychiatric disorders?. Australas Psychiatry. 2022, 30:530-2. 10.1177\/10398562221092310","journal-title":"Australas Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2010.05.006","article-title":"A randomized controlled trial of quetiapine versus placebo in the treatment of delirium","volume":"69","author":"Tahir TA","year":"2010","unstructured":"Tahir TA, Eeles E, Karapareddy V, et al.. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res. 2010, 69:485-90. 10.1016\/j.jpsychores.2010.05.006","journal-title":"J Psychosom Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/cc10450","article-title":"Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients with delirium: a post-hoc analysis of a double-blind, randomized, placebo-controlled study","volume":"15","author":"Devlin JW","year":"2011","unstructured":"Devlin JW, Skrobik Y, Riker RR, et al.. Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients with delirium: a post-hoc analysis of a double-blind, randomized, placebo-controlled study. Crit Care. 2011, 15:R215. 10.1186\/cc10450","journal-title":"Crit Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2022.10.010","article-title":"Pharmacologic treatment of delirium symptoms: a systematic review","volume":"79","author":"Sadlonova M","year":"2022","unstructured":"Sadlonova M, Duque L, Smith D, et al.. Pharmacologic treatment of delirium symptoms: a systematic review. Gen Hosp Psychiatry. 2022, 79:60-75. 10.1016\/j.genhosppsych.2022.10.010","journal-title":"Gen Hosp Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.4365","article-title":"Association of delirium response and safety of pharmacological interventions for the management and prevention of delirium: a network meta-analysis","volume":"76","author":"Wu YC","year":"2019","unstructured":"Wu YC, Tseng PT, Tu YK, et al.. Association of delirium response and safety of pharmacological interventions for the management and prevention of delirium: a network meta-analysis. JAMA Psychiatry. 2019, 76:526-35. 10.1001\/jamapsychiatry.2018.4365","journal-title":"JAMA Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.88a.20031","article-title":"Quetiapine for primary insomnia: consider the risks","volume":"88","author":"Modesto-Lowe V","year":"2021","unstructured":"Modesto-Lowe V, Harabasz AK, Walker SA. Quetiapine for primary insomnia: consider the risks. Cleve Clin J Med. 2021, 88:286-94. 10.3949\/ccjm.88a.20031","journal-title":"Cleve Clin J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2019.158460","article-title":"Delirium-informed care in emergency departments: diagnosis and beyond","volume":"38","author":"Tamune H","year":"2020","unstructured":"Tamune H. Delirium-informed care in emergency departments: diagnosis and beyond. Am J Emerg Med. 2020, 38:1684-5. 10.1016\/j.ajem.2019.158460","journal-title":"Am J Emerg Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/372376-management-of-subsyndromal-delirium-with-daridorexant-and-quetiapine-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:49:33Z","timestamp":1748872173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/372376-management-of-subsyndromal-delirium-with-daridorexant-and-quetiapine-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.85232","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,2]]}}}